20 min listen
Should We Screen Patients With HIV for NAFLD/NASH?
Should We Screen Patients With HIV for NAFLD/NASH?
ratings:
Length:
7 minutes
Released:
Nov 10, 2021
Format:
Podcast episode
Description
In this episode, hepatologist Giada Sebastiani, MD, discusses why the presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues can trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV with topics including:Metabolic factors HIV-related factorsWhich patients with HIV are at riskPresenter:Giada Sebastiani, MDAssociate Professor of MedicineMcGill University Health CentreDivision of Gastroenterology and Hepatology and Division of Infectious DiseasesClinician ScientistResearch Institute of McGill University Health CentreMontreal, Quebec, CanadaContent based on an online CME program supported by an educational grant from Theratechnologies Inc.Link to full program: https://bit.ly/3BYoXBP
Released:
Nov 10, 2021
Format:
Podcast episode
Titles in the series (100)
Benefits of and Need for Integrated Addiction and Infectious Disease Care: Listen to an insightful discussion between infectious disease experts, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, on current evidence supporting the need for integrated addiction and infectious disease care services. by CCO Infectious Disease Podcast